Joint Corp

Aktienanalyse zu Joint Corp (JYNT)

$7.370

-0.137 (-1.86%)Zum Schluss

Loading chart…
Hoch
7.630
Eröffnung
7.510
Volumengewichteter Durchschnittskurs
7.46
Volumen
59.83K
Marktkap.
204.84M
Tief
7.370
Umsatz
446.12K
EV/EBITDA, TTM
22.84

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

www.thejoint.com

KI-Analyse of Joint Corp (JYNT)

Kaufen

Joint Corp (JYNT) is a good buy right now due to its current price of $7.32, which is significantly below its 52-week high of $10.67, indicating potential for upside. The gross margin has improved to 80.90%, showcasing strong profitability, while insider buying has surged by 24955.71%, indicating confidence from those within the company. However, the main risk is the recent earnings surprise of -109.09%, which could impact investor sentiment.

Analystenbewertungen (3)

+53.73% Aufwärtspotenzial
Kaufen
3 Kaufen
0 Halten
0 Verkaufen
Aktuell: 7.37
Tief
9.00
Durchschnitt
11.33
Hoch
14.00

Roth Capital

2026-03-13

Kursziel

$12

Kaufen

B. Riley

2025-11-07

Kursziel

$9

Neutral

Lake Street

2025-11-07

Kursziel

$11

Kaufen

Roth Capital

2025-11-07

Kursziel

$14

Kaufen

Lake Street

2025-05-09

Kursziel

$16

Kaufen

Bewertungskennzahlen

Das aktuelle erwartete KGV von Joint Corp (JYNT) beträgt 9.47, verglichen mit dem 5-Jahres-Durchschnitt von 86.45.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
86.45
Aktuelles P/E
9.47
Überbewertet
182.44
Unterbewertet
-9.53

Erwartetes EV/EBITDA

Fair bewertet
5J-Durchschnitt EV/EBITDA
24.86
Aktuelles EV/EBITDA
22.84
Überbewertet
48.14
Unterbewertet
1.58

Erwartetes KUV

Fair bewertet
5J-Durchschnitt P/S
2.52
Aktuelles P/S
1.70
Überbewertet
4.51
Unterbewertet
0.52

Alphio-AI-Kursszenarien für JYNT

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%JYNT

$10.79

Szenariopreis

B

Basis

Basis · 50%JYNT

$9.39

Szenariopreis

B

Bärisch

Bärisch · 25%JYNT

$8.24

Szenariopreis

Event-Zeitleiste

2026-11-05 (ET)

17:30:00

The Joint Increases Stock Repurchase Authorization by $5 Million

17:30:00

The Joint Corp. Reports Q3 Revenue of $13.55M

2026-08-06 (ET)

17:30:00

The Joint Corp. Reports Q2 Revenue of $15.18M

17:30:00

Company Expects System-wide Sales Between $519 Million and $552 Million

2026-05-07 (ET)

17:30:00

The Joint Corp. Q1 Revenue $14.82M, Exceeds Expectations

News

JYNT FAQ – beantwortet von Alphio AI

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations. It operates in the Healthcare sector (PATENT OWNERS & LESSORS industry).

Joint Corp (JYNT) is a good buy right now due to its current price of $7.32, which is significantly below its 52-week high of $10.67, indicating potential for upside. The gross margin has improved to 80.90%, showcasing strong profitability, while insider buying has surged by 24955.71%, indicating confidence from those within the company. However, the main risk is the recent earnings surprise of -109.09%, which could impact investor sentiment.

3 analysts cover JYNT: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 11.33.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln